| Health / Medical Topics |
LY317615
A substance being studied in the treatment of certain types of cancer, including non-Hodgkin lymphoma, breast, colon, lung, ovarian, and prostate. LY317615 blocks certain cell signaling pathways, and may prevent the growth of new blood vessels that tumors need to grow. It is a type of serine threonine kinase inhibitor and a type of antiangiogenesis agent. Also called enzastaurin and enzastaurin hydrochloride. (NCI Dictionary)
YOU MAY ALSO LIKE
A substance that is being studied as a treatment for cancer. It belongs to the family of drugs called leukotriene B4 receptor…
A drug used alone or with another drug to treat certain types of non-small cell lung cancer and malignant pleural mesothelioma. It…
A surface receptor on NK cells involved in binding to MHC Class I molecules presented on somatic cells as part of a…
Describes a group of proteins in a cell that work together to help control how certain genes are expressed and how cholesterol,…
Derived from the original group of Syrian hamsters captured by Dr. Israel Aharoni in 1930 and imported into the United States in…
A whole-cell cancer vaccine, containing human acute myeloid leukemic (AML) blasts that have been genetically engineered to express a B7.1/IIL-2 fusion protein…
